Values of Enhanced Monitoring by EEG Recording (Narcotrend) for Sedation in Colonoscopy
1 other identifier
observational
200
1 country
1
Brief Summary
Endoscopic examinations and particularly long-lasting interventions can be uncomfortable for patients. Pain and vasovagal reactions are common. Therefore, the implementation is generally recommended under sedation and also carried out in practice here. The vital signs monitoring to avoid complications is dictated by current national guidelines. Necessary measures of monitoring include pulse oximetry and blood pressure measurements. In patients with severe heart disease an ECG recording should be used additionally. Moreover, the guidelines require that the sedation is clinically monitored continuously to avoid an unwanted anesthetic stage. Such evaluation, however, is often difficult under clinical conditions and even counterproductive, since a constant response and tactile stimulation of the patient (to check clinically the depth level of sedation ), interrupts endoscopic complex intervention. However, clinical most relevant aspect is the avoidance of unrecognized transition of patients from the stage of deep sedation in an anesthetic stage. Current recommendations do not take into account new study results from a gender perspective, which showed that women and men need a different wake-up time using the EEG derivation means by using the Narcotrend after total intravenous anesthesia, which may be due to different total doses of sedatives needed. However, the research group has been demonstrated in a previous study that most likely caused by the use of EEG monitoring (Narcotrend) an effective adaptation of sedation, in particular a more rapid recovery time by a lower dose of the administered sedative for a continuous sedation stage D0-D2 endoscopic retrograde cholangiopancreatography-(ERCP). In the presented study the investigators evaluate the extent of gender differences in the wake-up time after sedation with propofol during colonoscopy when using EEG monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 16, 2016
CompletedFirst Posted
Study publicly available on registry
February 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedMarch 8, 2016
February 1, 2016
1.9 years
February 16, 2016
March 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
mean recovery time after propofol sedation for colonoscopy using the EEG recording EEG monitoring at stage D0 to D2
Immediately after the procedure
Interventions
Value of EEG monitoring as adjunct to standard monitoring
Eligibility Criteria
Included are patients which is a , diagnostic or interventional colonoscopy under sedation with propofol.
You may qualify if:
- Age \> 18
- Clinical indication for colonoscopy
You may not qualify if:
- Lack of consent of the patient
- ASA (American Society of Anesthesiologists) class V
- Known Pregnancy
- Emergency investigations
- Pre-existent hypotension (RRsys \<90mmHg), bradycardia (HR \<50 / min), hypoxia (SaO2 \<90%)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinikum Agness Karll Laatzen
Laatzen, 30880, Germany
Related Publications (2)
Wehrmann T, Grotkamp J, Stergiou N, Riphaus A, Kluge A, Lembcke B, Schultz A. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc. 2002 Dec;56(6):817-24. doi: 10.1067/mge.2002.129603.
PMID: 12447291BACKGROUNDRiphaus A, Slottje M, Bulla J, Keil C, Mentzel C, Limbach V, Schultz B, Unzicker C. Women awaken faster than men after electroencephalogram-monitored propofol sedation for colonoscopy: A prospective observational study. Eur J Anaesthesiol. 2017 Oct;34(10):681-687. doi: 10.1097/EJA.0000000000000665.
PMID: 28873076DERIVED
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PD Dr. Andrea Riphaus
Study Record Dates
First Submitted
February 16, 2016
First Posted
February 22, 2016
Study Start
May 1, 2014
Primary Completion
April 1, 2016
Study Completion
July 1, 2016
Last Updated
March 8, 2016
Record last verified: 2016-02